Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

72.4K
Overview
72.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer.

Cancer science·2026
Same author

Correction: Generation of Human Melanocytes from Induced Pluripotent Stem Cells.

PloS one·2025
Same author

Iron-Deficiency Anemia Associated With Prostate Cancer, and Ameliorated by Anti-androgen Therapy.

Cureus·2025
Same author

Characterization of the N-terminal region of Crtac1B/LOTUS, an endogenous Nogo receptor-1 antagonist, required for secretion and soluble function.

Neuroscience letters·2025
Same author

A Comparison of Pumping Infusion-Induced Contamination With Different Syringe Types.

Journal of infusion nursing : the official publication of the Infusion Nurses Society·2024
Same author

Magnetic seizure therapy for depression in the very elderly: A report of two patients in their 80s.

Asian journal of psychiatry·2024

Related Experiment Video

Updated: Sep 10, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K

[CD8+ T Cells in Anti-Tumor Immune Response].

Shigeki Ohta1, Yutaka Kawakami

  • 1Dept. of Immunology, School of Medicine, International University of Health and Welfare.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 21, 2025
PubMed
Summary

Recent advances in multi-omics reveal CD8+ T cell dynamics crucial for effective cancer immunotherapy. Understanding T progenitor exhausted cells (Tpex) and their interactions enhances anti-tumor responses for better cancer vaccines and treatments.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

22.8K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.9K

Related Experiment Videos

Last Updated: Sep 10, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

22.8K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.9K

Area of Science:

  • Immunology
  • Oncology
  • Genomics

Background:

  • Traditional cancer vaccines show limited efficacy.
  • Immune checkpoint inhibitors (ICIs) demonstrate high therapeutic potential across various cancers.
  • Multi-omics technologies enable detailed single-cell analysis of immune cell dynamics.

Purpose of the Study:

  • To elucidate the in vivo dynamics of CD8+ T cells in cancer immunotherapy.
  • To identify key immune cell subsets and interactions within the tumor microenvironment.
  • To inform the development of novel cancer vaccine and combination immunotherapy strategies.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq)
  • Spatial transcriptomics
  • Multicolor immunostaining

Main Results:

  • CD8+ T cells are central to anti-tumor immunity, with diverse subsets identified.
  • T progenitor exhausted cells (Tpex) / stem cell memory T cells (TSCM) are crucial ICI targets within tumors and lymph nodes.
  • Interactions among CD4+ T cells, dendritic cells, B cells, and CD8+ T cells are vital for generating cytotoxic CD8+ effector T cells.

Conclusions:

  • A precise understanding of patient-specific CD8+ T cell dynamics is essential for enhancing immunotherapy.
  • Targeting Tpex/TSCM cells and optimizing immune cell interactions can improve anti-tumor effects.
  • This knowledge will advance vaccine therapies, combination immunotherapies, and cellular immunotherapy development.